• Work closely with the Clinical Sales Manager to gain knowledge in all aspects of the business including technical, clinical, and sales • Train to be a da Vinci® Surgery technical and sales expert • Support a specific region by maximizing the utilization of installed da Vinci® Surgical Systems • Lead product demonstrations/in-services and sales activities • Provide guidance, insight, and training on the use of the da Vinci® Surgical System • Contribute to Clinical Sales Manager team quarterly sales goals • Support and coordinate regional sales and marketing development events • Manage administrative tasks, including reporting of sales/procedures and submission of expense reports

• Assists sales representatives with surgeon trainings, hospitals robotic development, and overall territory management • Guides technical in-services for customers to include OR staff, surgeons, etc. • Sells benefits of advanced technology to existing robotic users to contribute to team overall quotas • Gains experience in goal setting, mapping, and attaining in preparation for quota bearing role to follow CTA position • Manages administrative tasks: reporting of sales/procedures, outcomes of sales activities, submission of expense reports

Role Description This is a policy and law reform role, not an operations or access role. The work is to change the rules — the federal policy and law governing clinical trials — so that more trials can be launched, run, and approved, faster and at lower cost. To be direct about scope: you will not be operating or running trials, and the role is not focused on trial access, diversity, inclusion, or equity. Those aims matter, but they are a different kind of work. This role exists to make trials themselves faster, cheaper, and more abundant to conduct — by reforming the system that governs them. This is a founding leadership role, working in close partnership with the initiative's Chief Science Officer to build the effort from the ground up. It runs on two horizons at once: - In the near term, you are the initiative's credible face in policy — the person who can sit across from a Senate HELP or House Energy & Commerce staffer, an FDA official, a hospital system's leadership, or a biotech CEO, and be taken seriously by all of them. - You help shape the legislative and regulatory reform agenda and drive it into the PDUFA 2027 window and its implementation. - Over the medium term, you build the field. There is no standing constituency for clinical trial abundance today; your job is to create one — a durable, formidable coalition of companies, investors, researchers, patient organizations, and policymakers who will carry this work long after any single legislative moment. Qualifications - Deep credibility in biotech, life sciences, or FDA / clinical-trial policy — this is a subject-matter role, not a generalist government-affairs one. - A track record of being taken seriously by senior, varied stakeholders: Hill offices, agencies, industry executives, investors, and researchers alike. - Evidence that you can build something durable, not only win a near-term legislative fight — coalition-building, institution-building, or genuine 0→1 experience. - Fluent in the case for reform that expands what's possible — cutting the friction, cost, and time between good science and the patients who need it. Requirements - Direct experience with PDUFA, user-fee reauthorizations, or FDA review-pathway reform. - Familiarity with international regulatory models (Australia, UK, EU). - An existing network spanning biotech, investors, research, and DC policy. Benefits - Competitive salary of 200000-250000 USD/year. - Private Health Insurance. - Paid Time Off. - Work From Home. - Training & Development.

• Support client engagements under direction of Senior Consultant • Form and restructure business entities • Prepare governance documents • Execute mergers and reorganizations for financial advisors • Prepare and assemble deliverables from templates • Coordinate meetings, filings, and timelines • Keep projects organized and follow through on details